| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 191.0 | 176.9 | 171.2 |
| Other income | 0.3 | 0.3 | 0.2 |
| Total income | 191.3 | 177.2 | 171.4 |
| Profit before exceptional items & tax | 0.7 | 0.3 | 0.1 |
| Exceptional items | 0.0 | 0.0 | 2.3 |
| Profit before tax | 0.7 | 0.3 | 2.5 |
| Net profit | -0.1 | 0.2 | 2.0 |
| Operating margin | 0.4% | 0.2% | 1.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +11.60% |
|---|
NSE results filing, NSE: CELLPOINT. Figures extracted from the filing.
Cell Point (India) Ltd: key numbers
- Share price
- ₹14.65
- Market cap
- ₹27.37 Cr
- Revenue (annual)
- ₹367.9 Cr
- Net profit (annual)
- ₹0.06 Cr
- P/E (TTM)
- 431.1×Sector 67.6×
- Promoter holding
- 73.06%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cell Point (India) Ltd
All →Cell Point (India) Annual Report
Cell Point (India) Limited issued a corrigendum to its FY 2025-26 Annual Report, including the previously omitted Form AOC-2. The revised report is available online.
Cell Point (India) Annual General Meeting
Cell Point (India) Limited has scheduled its 13th Annual General Meeting for September 29, 2026. The company fixed September 22, 2026, as the record date for voting.
Cell Point (India) Management Change
Cell Point (India) Limited announced the re-appointment of Mr. Mohan Prasad Panday as Managing Director and Mr. Bala Balaji Panday as Whole Time Director for five years.
- Execution
- 5 years
Cell Point (India) Board Meeting Outcome
Cell Point (India) Limited approved the notice for its 13th AGM and the re-appointment of directors during its board meeting.